关注
Matthias May
Matthias May
Professor der Medizin
在 klinikum-straubing.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation …
M May, S Brookman-Amissah, J Roigas, A Hartmann, S Störkel, ...
European urology 57 (5), 850-858, 2010
2162010
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort
A Aziz, M May, M Burger, RJ Palisaar, QD Trinh, HM Fritsche, M Rink, ...
European urology 66 (1), 156-163, 2014
2092014
High-pitch spiral computed tomography: effect on image quality and radiation dose in pediatric chest computed tomography
MM Lell, M May, P Deak, S Alibek, M Kuefner, A Kuettner, H Köhler, ...
Investigative radiology 46 (2), 116-123, 2011
2042011
Dose reduction in abdominal computed tomography: intraindividual comparison of image quality of full-dose standard and half-dose iterative reconstructions with dual-source …
MS May, W Wüst, M Brand, C Stahl, T Allmendinger, B Schmidt, M Uder, ...
Investigative radiology 46 (7), 465-470, 2011
1602011
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node–negative urothelial carcinoma of …
M May, E Herrmann, C Bolenz, S Brookman-May, A Tiemann, R Moritz, ...
Annals of surgical oncology 18, 2018-2025, 2011
1382011
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model …
S Brookman-May, M May, SF Shariat, E Xylinas, C Stief, R Zigeuner, ...
European urology 64 (3), 472-477, 2013
1212013
Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the …
R Mayr, M May, T Martini, M Lodde, E Comploj, A Pycha, J Strobel, ...
European urology 62 (4), 662-670, 2012
1102012
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
AO Siefker-Radtke, A Necchi, SH Park, J García-Donas, RA Huddart, ...
The Lancet Oncology 23 (2), 248-258, 2022
1052022
Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma
M May, S Brookman-Amissah, S Pflanz, J Roigas, B Hoschke, F Kendel
The British journal of radiology 82 (981), 724-731, 2009
1042009
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder
R Mayr, M May, T Martini, M Lodde, A Pycha, E Comploj, WF Wieland, ...
BJU international 110 (6b), E222-E227, 2012
1002012
Lymph node density affects cancer-specific survival in patients with lymph node–positive urothelial bladder cancer following radical cystectomy
M May, E Herrmann, C Bolenz, A Tiemann, S Brookman-May, HM Fritsche, ...
European urology 59 (5), 712-718, 2011
982011
Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the …
M May, T Nitzke, C Helke, H Vogler, B Hoschke
Scandinavian journal of urology and nephrology 38 (3), 231-235, 2004
982004
Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma–results from a comprehensive multi …
SD Brookman‐May, M May, SF Shariat, G Novara, R Zigeuner, L Cindolo, ...
BJU international 112 (7), 909-916, 2013
972013
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 …
W Otto, M May, HM Fritsche, D Dragun, A Aziz, M Gierth, L Trojan, ...
Gender medicine 9 (6), 481-489, 2012
962012
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder
P Nuhn, M May, M Sun, HM Fritsche, S Brookman-May, A Buchner, ...
European urology 61 (1), 58-64, 2012
942012
Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation
M May, C Helke, T Nitzke, H Vogler, B Hoschke
Urologia internationalis 72 (2), 103-111, 2004
902004
Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis
S Gunia, C Kakies, A Erbersdobler, OW Hakenberg, S Koch, M May
Journal of clinical pathology 65 (3), 232-236, 2012
882012
Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients
M May, N Knoll, M Siegsmund, D Fahlenkamp, H Vogler, B Hoschke, ...
The Journal of urology 178 (5), 1957-1962, 2007
852007
Prognostic impact of lymphovascular invasion in radical prostatectomy specimens
M May, O Kaufmann, F Hammermann, V Loy, M Siegsmund
BJU international 99 (3), 539-544, 2007
822007
Low-dose dual-source CT angiography with iterative reconstruction for coronary artery stent evaluation
J Eisentopf, S Achenbach, S Ulzheimer, C Layritz, W Wuest, M May, ...
JACC: Cardiovascular Imaging 6 (4), 458-465, 2013
792013
系统目前无法执行此操作,请稍后再试。
文章 1–20